Glomerulonephritis
Symptoms, Doctors, Treatments, Advances & More

Glomerulonephritis Overview

Save information for later
Sign Up

Learn About Glomerulonephritis

What is the definition of Glomerulonephritis?
Glomerulonephritis is a type of kidney disease in which there is inflammation of the glomeruli, the tiny filters that remove excess waste and fluids from the blood. It may be acute or chronic (coming on gradually), and may occur on its own (primary) or be caused by another condition (secondary). Signs and symptoms may depend on the type and cause of the condition and may include blood in the urine; foamy urine; swelling of the face, eyes, or other body parts; abdominal pain; high blood pressure; fatigue; and/or other symptoms. If the condition is severe or prolonged, the kidneys can become damaged. It may be caused by a variety of infections and diseases, and sometimes the cause is unknown.
What are the alternative names for Glomerulonephritis?
  • Glomerulonephritis
  • Bright's disease
Who are the top Glomerulonephritis Local Doctors?
Elite in Glomerulonephritis
Dr. Tripti Singh
Nephrology
Elite in Glomerulonephritis
Dr. Tripti Singh
Nephrology
Referral may be required

Fresenius Kidney Care Fitchburg Dialysis Center

3034 Fish Hatchery Rd, 
Fitchburg, WI 
608-733-3599
Languages Spoken:
English, Hindi
See accepted insurances
Accepting New Patients
Offers Telehealth

Tripti Singh is a Nephrologist practicing medicine in Fitchburg, Wisconsin. Dr. Singh is rated as an Elite provider by MediFind in the treatment of Glomerulonephritis. She is also highly rated in 21 other conditions, according to our data. Her clinical expertise encompasses Glomerulonephritis, Chronic Kidney Disease, Lupus Nephritis, End-Stage Renal Disease (ESRD), and Kidney Transplant. Dr. Singh is board certified in Internal Medicine and Nephrology. Dr. Singh is currently accepting new patients.

Elite in Glomerulonephritis
Dr. George C. Tsokos
Internal Medicine
Elite in Glomerulonephritis
Dr. George C. Tsokos
Internal Medicine
Before you request

BIDMC - Division Of Rheumatology

110 Francis Street, 
Boston, MA 
617-632-8658
Languages Spoken:
English, German, Greek
See accepted insurances
Accepting New Patients

George Tsokos is a primary care provider, practicing in Internal Medicine in Boston, Massachusetts. Dr. Tsokos is rated as an Elite provider by MediFind in the treatment of Glomerulonephritis. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Systemic Lupus Erythematosus (SLE), Lupus Nephritis, Glomerulonephritis, and Cutaneous Lupus Erythematosus (CLE). Dr. Tsokos is board certified in American Board Of Internal Medicine. Dr. Tsokos is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Glomerulonephritis
Dr. Betty Diamond
Internal Medicine
Elite in Glomerulonephritis
Dr. Betty Diamond
Internal Medicine
Before you request

Office

350 Community Dr, 
Manhasset, NY 
516-562-3830
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Betty Diamond is a primary care provider, practicing in Internal Medicine in Manhasset, New York. Dr. Diamond is rated as an Elite provider by MediFind in the treatment of Glomerulonephritis. She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Systemic Lupus Erythematosus (SLE), Lupus Nephritis, Glomerulonephritis, and Meningitis. Dr. Diamond is currently accepting new patients.

View All Doctors
What are the latest Glomerulonephritis Clinical Trials?
An Open-Label Phase 2 Study of N-Acetyl-D-Mannosamine (ManNAc) in Subjects With Podocyte Diseases
An Open-Label Phase 2 Study of N-Acetyl-D-Mannosamine (ManNAc) in Subjects With Podocyte Diseases
Enrollment Status: Recruiting
Publish Date: September 08, 2026
Intervention Type: Drug
Study Phase: Phase 2

Background: Podocyte diseases are a group of kidney conditions that include focal segmental glomerulosclerosis (FSGS), minimal change disease (MCD), and membranous nephropathy (MN). In these conditions, specialized kidney cells called podocytes, which help prevent protein from leaking into the urine, are damaged. This can result in high levels of protein in the urine and, over time, worsening kidney function....

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Multicentre, Randomised, Double-blind, Parallel Group, Placebo-controlled Trial to Assess the Effects of Oral TRPC6 Inhibitor BI 764198 Taken Over a 104 Week Treatment Period in Adult and Adolescent Participants With Primary Focal Segmental Glomerulosclerosis (pFSGS) or Genetic FSGS Related to TRPC6 Gene Variants
A Multicentre, Randomised, Double-blind, Parallel Group, Placebo-controlled Trial to Assess the Effects of Oral TRPC6 Inhibitor BI 764198 Taken Over a 104 Week Treatment Period in Adult and Adolescent Participants With Primary Focal Segmental Glomerulosclerosis (pFSGS) or Genetic FSGS Related to TRPC6 Gene Variants
Enrollment Status: Recruiting
Publish Date: September 08, 2026
Intervention Type: Drug
Study Phase: Phase 3

Summary: PODOMOUNT-pFSGS This study is open to adults and adolescents with a kidney condition called focal segmental glomerulosclerosis (FSGS). The purpose of this study is to find out whether a medicine called BI 764198 helps people with FSGS. Participants are put into 2 groups randomly, which means by chance. Every participant has an equal chance of being in each group. One group takes BI 764198 tablets,...

View All Clinical Trials
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center